- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Hodgkin's Disease
Total 384773 results
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
Memorial Sloan Kettering Cancer CenterCompletedIndolent Non-Hodgkin's LymphomaUnited States
-
Catherine BollardActive, not recruitingHodgkin Disease | Non Hodgkin Lymphoma | Leiomyosarcoma | Lymphoepithelioma | Severe Chronic Active EBV Infection Syndrome (SCAEBV)United States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedFollicular Lymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Non-Hodgkin's Lymphoma | Lymphoblastic Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia and other conditionsUnited States
-
University of NebraskaNational Cancer Institute (NCI)Terminated
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University of NebraskaSchering-PloughCompletedNon-Hodgkins LymphomaUnited States
-
Center for International Blood and Marrow Transplant...Sanofi; Genzyme, a Sanofi CompanyCompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Hodgkin's Disease | Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberUnited States
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, France, Ukraine, United Kingdom, China, Germany, Spain, Argentina, Belgium, Israel, Russian Federation, Turkey, Japan, Australia, Sweden, Korea, Republic of, Brazil, Puerto Rico, Poland
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
Case Comprehensive Cancer CenterCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | Acute Biphenotypic Leukemia | Hodgkins DiseaseUnited States
-
CelgeneCompleted
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
University of NebraskaNational Cancer Institute (NCI)Completed
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
University of California, DavisCelgeneActive, not recruitingNon Hodgkin's LymphomaUnited States
-
University of NebraskaCompleted
-
University of NebraskaNational Cancer Institute (NCI); Genentech, Inc.Completed
-
University of MiamiCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
St. Jude Children's Research HospitalCompleted
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
NCIC Clinical Trials GroupCompletedLymphomaUnited States, Canada, Australia
-
BiogenCompletedLymphoma, Non-Hodgkin | Lymphoma, Low-GradeUnited States
-
University of California, San FranciscoCompletedRefractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Plasma Cell Myeloma | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
TakedaActive, not recruitingHodgkin Disease | Lymphoma, T-Cell, CutaneousSpain
-
Vincerx Pharma, Inc.Active, not recruitingNeoplasmsUnited States, Chile, Spain
-
Memorial Sloan Kettering Cancer CenterPatient-Centered Outcomes Research Institute; Hackensack Meridian HealthActive, not recruitingMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Aggressive Non-Hodgkin... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, AIDS-relatedUnited States
-
University of RochesterCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Aprea TherapeuticsTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
NCIC Clinical Trials GroupCompleted
-
NCIC Clinical Trials GroupCompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificCanada
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); California Institute for Regenerative Medicine...Active, not recruitingHIV Infection | Plasmablastic Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Stage III Follicular... and other conditionsUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang University; The First Affiliated Hospital... and other collaboratorsSuspendedAcute Lymphoblastic Leukemia (ALL) | Non Hodgkin Lymphoma (NHL)China
-
AI Therapeutics, Inc.CompletedLymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticUnited States
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
West Virginia UniversityCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Non Hodgkin's LymphomaUnited States
-
ExelixisTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Non-Hodgkin's Lymphoma (NHL) | Mantle Cell Lymphoma (MCL) | Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)United States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Non Hodgkin Lymphoma | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Hemophagocytic Lymphohistiocytosis | Epstein Barr Virus Infection | X-linked Lymphoproliferative Disease | Hemophagocytic Syndrome | Familial Hemophagocytic LymphohistiocytosisUnited States
-
Fate TherapeuticsWithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin's Lymphoma